Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Marso

Showing results (71-80 of 143) with videos related to

Pageof 15
Sort By:
Circulation. Cardiovascular Quality and Outcomes|May 22, 2010
Cost-effectiveness of targeting patients undergoing percutaneous coronary intervention for therapy with bivalirudin versus heparin monotherapy according to predicted risk of bleedingAmit P Amin, Steven P Marso, Sunil V Rao, et al.
American Heart Journal|December 24, 2003
Evaluating the benefits of glycoprotein IIb/IIIa inhibitors in heart failure at baseline in acute coronary syndromesMonvadi B Srichai, Wael A Jaber, David L Prior, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 22, 2008
Vulnerable plaque intervention: State of the artJohn J Young, Harry R Phillips, Steven P Marso, et al.
Diabetology & Metabolic Syndrome|June 9, 2016
LEADER 7: cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differGuy E H M Rutten, Cees J Tack, Thomas R Pieber, et al.
Circulation. Cardiovascular Interventions|October 6, 2011
Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registryJason B Lindsey, Kevin F Kennedy, Joshua M Stolker, et al.
Circulation|January 24, 2002
Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trialMarino Labinaz, Rakhi Kilaru, Karen Pieper, et al.
Coronary Artery Disease|December 19, 2013
Compensatory enlargement of the left main coronary artery: insights from the PROSPECT studyShinji Inaba, Gary S Mintz, Takehisa Shimizu, et al.
JACC. Cardiovascular Interventions|January 26, 2013
Carotid artery stenting of a contralateral occlusion and in-hospital outcomes: results from the CARE (Carotid Artery Revascularization and Endarterectomy) registryNestor Mercado, David J Cohen, John A Spertus, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 7, 2011
Tissue characterisation of atherosclerotic plaque in the left main: an in vivo intravascular ultrasound radiofrequency data analysisNestor Mercado, Tabitha G Moe, Michael Pieper, et al.
The American Journal of Cardiology|October 31, 2013
Comparison of procedural complications with versus without interventional cardiology fellows-in-training during contemporary percutaneous coronary interventionJoshua M Stolker, Drew S Allen, David J Cohen, et al.
Pageof 15

Showing results (71-80 of 143) with videos related to

Sort By:
Pageof 15
Circulation. Cardiovascular Quality and Outcomes|May 22, 2010
Cost-effectiveness of targeting patients undergoing percutaneous coronary intervention for therapy with bivalirudin versus heparin monotherapy according to predicted risk of bleedingAmit P Amin, Steven P Marso, Sunil V Rao, et al.
American Heart Journal|December 24, 2003
Evaluating the benefits of glycoprotein IIb/IIIa inhibitors in heart failure at baseline in acute coronary syndromesMonvadi B Srichai, Wael A Jaber, David L Prior, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 22, 2008
Vulnerable plaque intervention: State of the artJohn J Young, Harry R Phillips, Steven P Marso, et al.
Diabetology & Metabolic Syndrome|June 9, 2016
LEADER 7: cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differGuy E H M Rutten, Cees J Tack, Thomas R Pieber, et al.
Circulation. Cardiovascular Interventions|October 6, 2011
Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registryJason B Lindsey, Kevin F Kennedy, Joshua M Stolker, et al.
Circulation|January 24, 2002
Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trialMarino Labinaz, Rakhi Kilaru, Karen Pieper, et al.
Coronary Artery Disease|December 19, 2013
Compensatory enlargement of the left main coronary artery: insights from the PROSPECT studyShinji Inaba, Gary S Mintz, Takehisa Shimizu, et al.
JACC. Cardiovascular Interventions|January 26, 2013
Carotid artery stenting of a contralateral occlusion and in-hospital outcomes: results from the CARE (Carotid Artery Revascularization and Endarterectomy) registryNestor Mercado, David J Cohen, John A Spertus, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 7, 2011
Tissue characterisation of atherosclerotic plaque in the left main: an in vivo intravascular ultrasound radiofrequency data analysisNestor Mercado, Tabitha G Moe, Michael Pieper, et al.
The American Journal of Cardiology|October 31, 2013
Comparison of procedural complications with versus without interventional cardiology fellows-in-training during contemporary percutaneous coronary interventionJoshua M Stolker, Drew S Allen, David J Cohen, et al.
Pageof 15